These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 19882681
1. Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields. Girgert R, Hanf V, Emons G, Gründker C. Bioelectromagnetics; 2010 Apr; 31(3):237-45. PubMed ID: 19882681 [Abstract] [Full Text] [Related]
2. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. Girgert R, Hanf V, Emons G, Gründker C. J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736 [Abstract] [Full Text] [Related]
3. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines. Lai L, Yuan L, Cheng Q, Dong C, Mao L, Hill SM. Breast Cancer Res Treat; 2009 Nov; 118(2):293-305. PubMed ID: 18979234 [Abstract] [Full Text] [Related]
4. Effects of 60-Hz fields, estradiol and xenoestrogens on human breast cancer cells. Dees C, Garrett S, Henley D, Travis C. Radiat Res; 1996 Oct; 146(4):444-52. PubMed ID: 8927716 [Abstract] [Full Text] [Related]
5. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines. Treeck O, Haldar C, Ortmann O. Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061 [Abstract] [Full Text] [Related]
6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
7. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells. Detry C, Lamour V, Castronovo V, Bellahcène A. Bone; 2008 Feb; 42(2):422-31. PubMed ID: 18088579 [Abstract] [Full Text] [Related]
8. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation. Jawed S, Kim B, Ottenhof T, Brown GM, Werstiuk ES, Niles LP. Eur J Pharmacol; 2007 Mar 29; 560(1):17-22. PubMed ID: 17303109 [Abstract] [Full Text] [Related]
10. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells. Treeck O, Lattrich C, Springwald A, Ortmann O. Breast Cancer Res Treat; 2010 Apr 29; 120(3):557-65. PubMed ID: 19434490 [Abstract] [Full Text] [Related]
15. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M. Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749 [Abstract] [Full Text] [Related]
16. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines. Mohamood AS, Gyles P, Balan KV, Hollis VW, Eckberg WR, Asseffa A, Han Z, Wyche JH, Anderson WA. J Submicrosc Cytol Pathol; 1997 Jan 01; 29(1):1-17. PubMed ID: 9066137 [Abstract] [Full Text] [Related]
17. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Chen C, Chang YC, Liu CL, Chang KJ, Guo IC. Breast Cancer Res Treat; 2006 Jul 01; 98(2):121-32. PubMed ID: 16752079 [Abstract] [Full Text] [Related]
18. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells. Srivastava P, Russo J, Mgbonyebi OP, Russo IH. Anticancer Res; 1998 Jul 01; 18(6A):4003-10. PubMed ID: 9891438 [Abstract] [Full Text] [Related]
19. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP. Clin Cancer Res; 2005 May 01; 11(9):3184-90. PubMed ID: 15867211 [Abstract] [Full Text] [Related]
20. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. Hu M, Wang J, Chen P, Reilly RM. Bioconjug Chem; 2006 May 01; 17(5):1280-7. PubMed ID: 16984139 [Abstract] [Full Text] [Related] Page: [Next] [New Search]